Society for Maternal-Fetal Medicine Special Statement: COVID-19 research in pregnancy: progress and potential - 27/11/21
Research Committee
Society for Maternal-Fetal Medicine (SMFM)
Rupsa C. Boelig, MD, MS, Kjersti M. Aagaard, MD, PhD, Michelle P. Debbink, MD, PhD, Alireza A. Shamshirsaz, MDSMFM Research Committee⁎
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy. Research is the basis for evidence-based clinical guidelines, and we aim to provide the structure and guidance for framing COVID-19–related obstetrical research. This structure will pertain not only to this pandemic but future ones as well.
Le texte complet de cet article est disponible en PDF.Key words : COVID-19 pandemic, fetal outcomes, healthcare policy, maternal outcomes, neonatal outcomes, obstetrical research
Plan
| All authors and Committee members have filed a disclosure of interest delineating personal, professional, and/or business, or other relevant financial or nonfinancial interests in relation to this publication. All conflicts have been resolved through a process approved by the Society for Maternal-Fetal Medicine (SMFM) Board of Directors. SMFM has neither solicited nor accepted any commercial involvement in the specific development of the content of this publication. |
|
| There was no specific funding for this commentary. R.C.B. is supported by a PhRMA Foundation Faculty Development Award. M.P.D. is supported by the March of Dimes and American Board of Obstetrics and Gynecology as part of the Reproductive Scientist Development Award. |
|
| This document has undergone an internal peer review through a multilevel committee process within SMFM. This review involves critique and feedback from the SMFM Research Committee Document Review Committees and final approval by the SMFM Executive Committee. SMFM accepts sole responsibility for document content. SMFM publications do not undergo editorial and peer review by the American Journal of Obstetrics & Gynecology. Further details regarding SMFM publications can be found at publications. |
|
| SMFM recognizes that obstetrical patients have diverse gender identities and is striving to use gender-inclusive language in all of its publications. SMFM will be using the terms “pregnant person or persons” or “pregnant individual or individuals” instead of “pregnant woman or women” and will be using the singular pronoun “they.” When describing study populations used in research, SMFM will use the gender terminology reported by the study investigators. |
|
| Reprints will not be available. |
Vol 225 - N° 6
P. B19-B31 - décembre 2021 Retour au numéro
Article précédent
- Society for Maternal-Fetal Medicine Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine
- Society for Maternal-Fetal Medicine (SMFM), Matthew A. Shanahan, Kjersti M. Aagaard, Laurence B. McCullough, Francis A. Chervenak, Alireza A. Shamshirsaz
Bienvenue sur EM-consulte, la référence des professionnels de santé.